Assura PLC
LSE:AGR

Watchlist Manager
Assura PLC Logo
Assura PLC
LSE:AGR
Watchlist
Price: 47.48 GBX 0.38% Market Closed
Market Cap: £1.5B

Assura PLC
Investor Relations

In the ever-evolving landscape of healthcare infrastructure, Assura PLC has carved out a niche, specializing in the development and management of primary care properties across the UK. With a keen understanding of the public and private sector disparities within the healthcare industry, Assura operates essentially as a real estate investment trust (REIT), focusing on assets that provide essential healthcare services. Their business model is grounded in creating and maintaining robust and modern facilities that serve as the backbone for general practitioners, dentists, and other community health services. By partnering with the National Health Service (NHS), Assura ensures that these facilities not only meet current standards but also anticipate future healthcare needs, ensuring long-term sustainability and growth opportunities.

Revenue generation for Assura PLC primarily revolves around rental income derived from the leasing of these healthcare properties. With a portfolio spanning several hundred properties, Assura capitalizes on long-term leases, often with inflation-linked rent reviews, providing them with a stable and predictable income. This strategy affords them the advantage of minimizing vacancy risks, given their collaboration with the NHS and the ongoing demand for modern healthcare facilities. By focusing on niche real estate like medical centers and community hospitals, Assura aligns its financial objectives with the critical needs of public health infrastructure, positioning itself as an essential player in ensuring the organic expansion of primary healthcare services throughout the UK.

Show more
Loading
AGR
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2025
Call Date
Nov 14, 2024
AI Summary
Q2 2025

Portfolio Transformation: Assura acquired a GBP 500 million portfolio of 14 private hospitals, significantly diversifying its healthcare real estate assets and immediately increasing asset value.

Financial Growth: Net rental income grew 8% and earnings increased 4%, with rent roll rising to GBP 179.1 million. EPRA earnings reached GBP 52.7 million.

Dividend & Yield: Dividend increased by 4%, and shares now yield over 8%, supported by index-linked leases and earnings growth.

Balance Sheet Actions: Loan-to-value was reduced from 49% to under 48% post-disposals, with more disposals in the pipeline expected to bring it down to 45% within 3–6 months.

Strategic Outlook: Management highlighted strong demand drivers, political support for NHS investment, and a positive outlook for both primary care and private hospital markets.

Development Pipeline: NHS development pipeline is on hold due to rent constraints, but private hospital activity and demand are increasing.

ESG & B Corp: Achieved B Corp accreditation and committed to science-based environmental targets, highlighting sustainability initiatives.

Guidance & Engagement: Management expects continued rental growth, active engagement with the new government, and sees opportunities aligned to future NHS funding and policy changes.

Key Financials
Net Rental Income
GBP 76.7 million
EPRA Earnings
GBP 52.7 million
Rent Roll
GBP 179.1 million
Dividend
up 4%
EPRA EPS
GBP 0.0172 per share
EPRA Cost Ratio
12%
NTA (Net Tangible Asset Value) per share
GBP 0.494
Loan-to-Value (LTV)
under 48%
Interest Rate
3%
Dividend Yield
over 8%
Rent Cover (Private Hospitals)
2.3x
Hospital Portfolio Acquisition Cost
GBP 500 million
Hospital Portfolio Value Uplift
GBP 25 million
Loan for Hospital Acquisition
GBP 266 million
Yield on Cost (Hospital Portfolio)
5.9%
Weighted Average Unexpired Lease Term (Hospital Portfolio)
26 years
Assets Sold (Disposal Program)
12 assets for GBP 25 million
Rent Roll Index-Linked or Fixed Uplifts
close to 50%
Rent Review Uplift
8.2%
Earnings Call Recording
Other Earnings Calls
2025
2023
2022
2021

Management

Mr. Jonathan Stewart Murphy ACA, MBA
CEO & Executive Director
No Bio Available
Ms. Jayne Marie Cottam
CFO & Executive Director
No Bio Available
Ms. Sian Taylor
Group Operations Director
No Bio Available
Mr. Steven Noble
Chief Investment Officer
No Bio Available
Ms. Joanne Cullen
Senior Management Accountant
No Bio Available
Mr. David Purcell
Investor Relations Director
No Bio Available
Ms. Orla Ball
General Counsel
No Bio Available
Ms. Debbie Chalcraft
Group Compliance Manager
No Bio Available
Ms. Sarah Taylor
Chief People Officer
No Bio Available
Ms. Francesca Harris
Interim Head of Communications
No Bio Available

Contacts

Address
CHESHIRE
Warrington
The Brew House, Greenalls Avenue
Contacts
+441925420660.0
www.assuraplc.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett